The latest prostate cancer news
Low risk of cancer spread on active surveillance for early prostate cancer
Men undergoing active surveillance for prostate cancer have very low rates – one percent or…
Browsing: Prostate Cancer
Prostate cancer drug targeting Achilles heel approved in Europe
The Institute of Cancer Research, London, UK, has strongly welcomed the approval by the European…
ICR welcomes NICE’s decision to reassess abiraterone as first-line treatment for advanced prostate cancer
The Institute of Cancer Research, London, UK, has welcomed the announcement by NICE that it…
Study examines health literacy and shared decision-making in prostate cancer screening
New research examines the dynamics between men’s health literacy, their discussions with their doctors, and…
Olaparib approved in Europe for prostate cancer
The Institute of Cancer Research, London, UK, has strongly welcomed the approval by the European…
Cancer Experts Welcome Medicare Changes to Empower Men with Prostate Cancer
The Royal Australian and New Zealand College of Radiologists (RANZCR), the Urological Society of Australia…
ASTRO 2020: MFS Is a strong surrogate endpoint for OS for men receiving salvage RT for recurrent prostate cancer
An analysis of the phase III NRG Oncology clinical trial RTOG 9601 on men receiving…
Outcomes of salvage low dose RT brachytherapy after EBRT for prostate cancer
Researchers involved in the phase II NRG Oncology RTOG 0526 trial studying low dose rate…
18F-Fluciclovine PET/MRI for prostate cancer staging, androgen deprivation evaluation
According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), fluorine-18-labeled fluciclovine PET/MRI demonstrated utility…
Adding advanced PET scans to radiation plans for prostate cancer increases FFS rates
Adding the advanced PET radiotracer fluciclovine to conventional imaging to help guide radiation treatments for…